APA

Muhs A., Heublein B., Schletter J., Herrmann A., Rüdiger M., Sturm M., Grust A., Malms J., Schrader J. & von der Leyen H. E. (20030926). Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. : Human gene therapy.

Chicago

Muhs Andreas, Heublein Bernd, Schletter Jens, Herrmann Andreas, Rüdiger Manfred, Sturm Matthias, Grust Andreas, Malms Jochen, Schrader Jürgen and von der Leyen Heiko E. 20030926. Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. : Human gene therapy.

Harvard

Muhs A., Heublein B., Schletter J., Herrmann A., Rüdiger M., Sturm M., Grust A., Malms J., Schrader J. and von der Leyen H. E. (20030926). Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. : Human gene therapy.

MLA

Muhs Andreas, Heublein Bernd, Schletter Jens, Herrmann Andreas, Rüdiger Manfred, Sturm Matthias, Grust Andreas, Malms Jochen, Schrader Jürgen and von der Leyen Heiko E. Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. : Human gene therapy. 20030926.